[1] |
Ryan G, Martinelli G, Kuper-Hommel M, et al. Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the international extranodal lymphoma study group [J]. Ann Oncol, 2008, 19(2): 233-241.
|
[2] |
Thomas A, Link BK, Altekruse S, et al. Primary breast lymphoma in the united states: 1975-2013 [J]. J Natl Cancer Inst, 2017, 109(6): djw294.
|
[3] |
Aviles A, Delgado S, Nambo MJ, et al. Primary breast lymphoma: results of a controlled clinical trial [J]. Oncology, 2005, 69(3): 256-260.
|
[4] |
Zhao YF, Jiao F, Liang HQ, et al. Primary malignant non-hodgkin’s lymphoma of the breast: a case report [J]. Oncol Lett, 2014, 8(6): 2597-2600.
|
[5] |
Aviv A, Tadmor T, Polliack A. Primary diffuse large b-cell lymphoma of the breast: looking at pathogenesis, clinical issues and therapeutic options [J]. Ann Oncol, 2013, 24(9): 2236-2244.
|
[6] |
Cheah CY, Campbell BA, Seymour JF. Primary breast lymphoma [J]. Cancer Treat Rev, 2014, 40(8): 900-908.
|
[7] |
Hosein PJ, Maragulia JC, Salzberg MP, et al. A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era [J]. Br J Haematol, 2014, 165(3): 358-363.
|
[8] |
Nichter LS, Mueller MA, Burns RG, et al. First report of nodal marginal zone B-cell lymphoma associated with breast implants [J]. Plast Reconstr Surg, 2012, 129(3): 576e-578e.
|
[9] |
Rupani A, Frame JD, Kamel D. Lymphomas associated with breast implants: a review of the literature [J]. Aesthet Surg J, 2015, 35(5): 533-544.
|
[10] |
De Jong D, Vasmel WL, De Boer JP, et al. Anaplastic large-cell lymphoma in women with breast implants [J]. JAMA, 2008, 300(17): 2030-2035.
|
[11] |
Miranda RN, Aladily TN, Prince HM, et al. Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients [J]. J Clin Oncol, 2014, 32(2): 114-120.
|
[12] |
Avenia N, Sanguinetti A, Cirocchi R, et al. Primary breast lymphomas: a multicentric experience [J]. World J Surg Oncol, 2010, 8:53.
|
[13] |
Jung SP, Kim M, Han KM, et al. Primary breast lymphoma: a single institution’s experience [J]. J Korean Surg Soc, 2013, 84(5): 267-272.
|
[14] |
Inic Z, Inic M, Zegarac M, et al. Three cases of combined therapy in primary breast lymphoma (pbl) with successful outcomes [J]. Clin Med Insights Oncol, 2013, 7:159-163.
|
[15] |
Domchek SM, Hecht JL, Fleming MD, et al. Lymphomas of the breast: primary and secondary involvement [J]. Cancer, 2002, 94(1): 6-13.
|
[16] |
Jabbour G, El-Mabrok G, Al-Thani H, et al. Primary breast lymphoma in a woman: a case report and review of the literature [J]. Am J Case Rep, 2016, 17:97-103.
|
[17] |
Surov A, Holzhausen HJ, Wienke A, et al. Primary and secondary breast lymphoma: prevalence, clinical signs and radiological features [J]. Br J Radiol, 2012, 85(1014): e195-205.
|
[18] |
Wiseman C, Liao KT. Primary lymphoma of the breast [J]. Cancer, 1972, 29(6): 1705-1712.
|
[19] |
Jeanneret-Sozzi W, Taghian A, Epelbaum R, et al. Primary breast lymphoma: patient profile, outcome and prognostic factors. a multicentre rare cancer network study [J]. BMC Cancer, 2008, 8:86.
|
[20] |
Jennings WC, Baker RS, Murray SS, et al. Primary breast lymphoma: the role of mastectomy and the importance of lymph node status [J]. Ann Surg, 2007, 245(5): 784-789.
|
[21] |
Caon J, Wai ES, Hart J, et al. Treatment and outcomes of primary breast lymphoma [J]. Clin Breast Cancer, 2012, 12(6): 412-419.
|
[22] |
Martelli M, Ferreri AJ, Agostinelli C, et al. Diffuse large B-cell lymphoma [J]. Crit Rev Oncol Hematol, 2013, 87(2): 146-171.
|
[23] |
Yhim HY, Kang HJ, Choi YH, et al. Clinical outcomes and prognostic factors in patients with breast diffuse large b cell lymphoma; consortium for improving survival of lymphoma (CISL) study [J]. BMC Cancer, 2010, 10:321.
|
[24] |
Wadhwa A, Senebouttarath K. Primary lymphoma of the breast: a case series [J]. Radiol Case Rep, 2018, 13(4): 815-821.
|
[25] |
Coiffier B, Lepage E, Briere J, et al. Chop chemotherapy plus rituximab compared with chop alone in elderly patients with diffuse large-B-cell lymphoma [J]. New Engl J Med, 2002, 346(4): 235-242.
|
[26] |
Shao YB, Sun XF, He YN, et al. Clinicopathological features of thirty patients with primary breast lymphoma and review of the literature [J]. Med Oncol, 2015, 32(2): 448.
|
[27] |
Millis RR, Bobrow LG, Rubens RD, et al. Histiocytic lymphoma of breast responds to tamoxifen [j]. Br J Cancer, 1988, 58(6): 808-809.
|
[28] |
Scariano JK, Emery-Cohen AJ, Pickett GG, et al. Estrogen receptors alpha (esr1) and beta (esr2) are expressed in circulating human lymphocytes [J]. J Recept Signal Transduct Res, 2008, 28(3): 285-293.
|
[29] |
Shim GJ, Gherman D, Kim HJ, et al. Differential expression of oestrogen receptors in human secondary lymphoid tissues [J]. J Pathol, 2006, 208(3): 408-414.
|